Alternative and Complementary Therapies for Cancer [recurso electrónico] : Integrative Approaches and Discovery of Conventional Drugs / edited by Moulay Alaoui-Jamali.
Tipo de material: TextoEditor: Boston, MA : Springer US : Imprint: Springer, 2010Descripción: XX, 722p. 32 illus. online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9781441900203Tema(s): Medicine | Toxicology | Alternative medicine | Oncology | Medicine & Public Health | Oncology | Complementary & Alternative Medicine | Pharmacology/ToxicologyFormatos físicos adicionales: Printed edition:: Sin títuloClasificación CDD: 616.994 Clasificación LoC:RC254-282Recursos en línea: Libro electrónicoTipo de ítem | Biblioteca actual | Colección | Signatura | Copia número | Estado | Fecha de vencimiento | Código de barras |
---|---|---|---|---|---|---|---|
Libro Electrónico | Biblioteca Electrónica | Colección de Libros Electrónicos | RC254 -282 (Browse shelf(Abre debajo)) | 1 | No para préstamo | 371079-2001 |
Overview of Efficacy and Limitation of Standard and Targeted Therapy for Malignant Disease Using Lung Cancer as a Case Study -- Integrative Complementary and Alternative Medicine for Cancer Care -- Overview of Current TCM Practice and Potential Impacts on Conventional Therapies -- Complementary and Alternative Medicine for Cancer Care in India: Basic and Clinical Perspectives -- Complementary and Alternative Medicine for Cancer Care in India: Basic and Clinical Perspective -- Integrated TCM for Cancer Care in China: Principles, Recipes, and Case Studies for Selected Sites -- Esophageal Cancer -- Gastric Cancer -- Colorectal Cancer -- Liver Cancer -- Pancreatic Cancer -- Breast Cancer -- Ovarian Cancer -- Prostate Cancer -- Kidney Cancer -- Bladder Cancer -- Brain Cancer -- Management of Complementary and Alternative Treatments for Cancer -- Complementary and Alternative Treatments for the Management of Cancer-Related Fatigue -- Complementary and Alternative Treatments for the Management of Cancer-Related Pain -- Clinical, Pharmacological, and Safety Issues Using Complementary Therapies -- Challenges Conducting Clinical Trials with Herbal Products in Oncology -- Herbal Product–Drug Interactions from a Pharmacological Perspective -- Patient–Physician Relationship -- Patient–Physician Relationship: Creating an Optimal Healing Environment -- Regulatory Issues -- Legal Issues in Alternative Treatment of Cancer -- Intellectual Property for Alternative Medicine -- From Practice to Basics -- Chemical-Biology of Natural Products from Medicinal Plants for Cancer Therapy -- Flavonoids in Cancer Prevention and Therapy: Chemistry, Pharmacology, Mechanisms of Action, and Perspectives for Cancer Drug Discovery -- Marine Natural Products and their Synthetic Derivatives for Cancer Therapy -- Natural Product-like Scaffolds for Molecular Dissection of Macromolecular Interactions and New Therapeutic Applications -- Mining Natural Product-Derived Molecules Against Cancer Targets: The Case of the Androgen Receptor in Prostate Cancer.
Management of advanced cancers by modern therapies can be hampered by the unavailability of efficient drugs, which explains in part the high mortality rates seen in patients with advanced cancers. Alternative therapies, particularly those using formulations derived from herbal, marine and animal products, are rich sources of chemically diverse and complex molecules with the potential to discover novel drugs. Alternative and Complementary Therapies for Cancer is unique in the field, as it presents the progress and limitations of alternative therapies through an unusual interface of traditional and modern concepts assembled by recognized experts (from China, India, USA, Canada, and Europe) in medical oncology, alternative medicine, cancer pharmacology and medicinal chemistry. Current developments from clinical and regulatory perspectives are presented, areas of controversy and potential integration of alternative and complementary therapies are highlighted, and future perspectives for the discovery of herbal constituents that may complement anticancer drugs are discussed.
19